Home / Cd276 Knockout Cell Lines

Cd276 Knockout Cell Lines

Gene: Cd276

Official Full Name: CD276 antigenprovided by MGI

Gene Summary: Enables identical protein binding activity and signaling receptor binding activity. Acts upstream of or within several processes, including positive regulation of osteoblast differentiation; regulation of T cell proliferation; and regulation of cytokine production. Located in external side of plasma membrane. Is expressed in several structures, including embryo endoderm; genitourinary system; hemolymphoid system; liver; and musculoskeletal system. Orthologous to human CD276 (CD276 molecule). [provided by Alliance of Genome Resources, Apr 2025]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO01154 Cd276 knockout cell line (MC38) Mouse Cd276 1:2-1:4 Negative Online Inquiry

Background

Cd276 Gene Knockout Cell Lines are specialized cellular models designed to enable the study of the Cd276 gene, also known as PD-L1. This gene encodes a protein that plays a pivotal role in modulating immune responses, particularly in the context of cancer immunotherapy. By introducing targeted genomic modifications, these knockout cell lines are engineered to lack the expression of the Cd276 gene, allowing researchers to investigate the biological implications of disabling this checkpoint protein.

The key function of Cd276 Gene Knockout Cell Lines lies in their ability to elucidate the mechanisms of immune evasion employed by tumor cells. Without the Cd276 protein, researchers can study the resultant changes in immune cell activation and the overall tumor microenvironment. This capability allows for a detailed analysis of immune responses, offering insights into how tumors can escape immune surveillance, which is crucial for developing effective therapeutic strategies.

The scientific importance of these cell lines extends across basic and applied research. In pre-clinical studies, they can be utilized to evaluate the effectiveness of novel immunotherapies that target the PD-L1 pathway, providing a platform for drug testing and validation. In clinical settings, understanding the role of the Cd276 gene can aid in identifying biomarkers for patient stratification, ultimately enhancing personalized medicine approaches in oncology.

What sets Cd276 Gene Knockout Cell Lines apart from conventional cell models is their specificity and precision. While standard cell lines may express PD-L1, the knockout variant allows for an unambiguous study of its effects, minimizing confounding variables. Moreover, these knockout lines can be paired with various immunological assays, thus facilitating versatile experimentation that can lead to reproducible and robust results.

For researchers and clinicians seeking to advance their understanding of immune regulation in cancer, the Cd276 Gene Knockout Cell Lines represent an invaluable tool. By enabling a clearer exploration of the immune landscape in tumor biology, this product supports critical developments in both research and therapeutic avenues. Our company specializes in providing high-quality biological products designed to meet the rigorous demands of scientific investigation, ensuring that our offerings are both reliable and innovative for the advancement of health and therapeutics.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.